Scientists from Nigeria, Sierra Leone, and the US have developed a point-of-care test for both the Lassa virus and Ebola virus that is accurate, fast, and cheap.The test is based on SHERLOCK a new diagnostic that uses CRISPR technology to detect genetic fingerprints that indicate the presence of pathogens in a sample. The test can be done in any environment with minimal equipment powered with solar panels or a small generator.